CLARENCE W LEGERTON M.D. NPI 1285732214

NPI Information

  • NPI: 1285732214
  • Provider Name: CLARENCE W LEGERTON, M.D.
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • Address: 2001 2ND AVE STE 201
    SUMMERVILLE, SC
    ZIP 29486
  • Phone: (843) 572-4840

Map and Directions

Get Directions

NPI Details

Clarence W Legerton, M.D. is a rheumatology internal medicine in Summerville, SC. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Clarence W Legerton, M.D. NPI is 1285732214. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

2001 2ND AVE STE 201
SUMMERVILLE, SC
ZIP 29486
Phone: (843) 572-4840
Fax: (843) 764-2726

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Injection, tocilizumab, 1 mg (HCPCS:J3262)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
  • Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
  • Injection, infliximab-abda, biosimilar, (renflexis), 10 mg (HCPCS:Q5104)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg (HCPCS:Q5103)
  • Injection, rituximab, 10 mg (HCPCS:J9312)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
  • Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • X-ray of hand, 2 views (HCPCS:73120)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Analysis of substance using immunoassay technique, multiple step method (HCPCS:83516)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • X-ray of foot, 2 views (HCPCS:73620)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
  • Vitamin d-3 level (HCPCS:82306)
  • Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
  • Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
  • Uric acid level, blood (HCPCS:84550)
  • X-ray of knee, 1-2 views (HCPCS:73560)
  • Tuberculosis test, gamma interferon (HCPCS:86480)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
  • Rheumatoid factor level (HCPCS:86431)
  • Screening test for autoimmune disorder (HCPCS:86038)
  • Measurement of dna antibody, native or double stranded (HCPCS:86225)
  • Measurement of dna antibody, single stranded (HCPCS:86226)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)

The enumeration date for this NPI number is 9/21/2006 and was last updated on 9/13/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RR0500XInternal MedicineRheumatology16182SOUTH CAROLINAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.